Biodexa Pharmaceuticals Plc

BDRX chart

Biodexa Pharmaceuticals Plc news

• Biodexa Pharmaceuticals plc Estimates – NASDAQ:BDRX

  TradingView · Oct 23, 9:38 AM EDT

• European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading

  Yahoo Finance · Oct 14, 11:10 AM EDT

• Biodexa Reaches 100-Patient Enrollment Milestone in Phase 3 Serenta Trial as Key Analysis Timeline Accelerates

  investorshub.advfn.com · Oct 13, 9:51 AM EDT

• Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP

  Yahoo Finance · Oct 13, 8:30 AM EDT

• The Longview: Fireside Chat with Biodexa CEO Stephen Stamp

  Yahoo Finance · Sep 23, 6:30 AM EDT

• BDRX: Enrollment in Phase 3 SERENTA Trial Reaches 92 Patients

  Yahoo Finance · Sep 22, 7:26 AM EDT

• Biodexa Enters Into Warrant Exercise Transaction for $2.3 Million in Gross Proceeds

  Yahoo Finance · Sep 15, 8:00 AM EDT

• Interim results for the six months ended June 30, 2026

  Yahoo Finance · Sep 11, 4:30 PM EDT

• European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading

  Yahoo Finance · Sep 11, 11:13 AM EDT

• European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading

  Yahoo Finance · Sep 2, 11:13 AM EDT

• Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP

  Yahoo Finance · Aug 19, 8:30 AM EDT

• European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

  Yahoo Finance · Aug 3, 11:05 AM EDT

Biodexa Pharmaceuticals Plc key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KFORM 6-K2026-10-14
• 6-KReport (foreign issuer)2026-10-08
• 6-KReport (foreign issuer)2026-09-15
• 6-KReport (foreign issuer)2026-09-11
• 6-KReport (foreign issuer)2026-07-29
• 6-KReport (foreign issuer)2026-07-09
• 6-KFORM 6-K2026-06-30
• 6-KReport (foreign issuer)2026-06-30
• 6-KReport (foreign issuer)2026-06-17
• 6-KReport (foreign issuer)2026-05-14
• 20-FAnnual report (foreign issuer)2026-03-27
• 6-KFORM 6-K2026-03-27

About Biodexa Pharmaceuticals Plc

Ticker

BDRX (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Cardiff

Incorporated in

United Kingdom

Fiscal year end

December 31

SEC CIK

1643918

Former names

Midatech Pharma Plc

Frequently asked questions